Clinical Trials Browser

Head and Neck Neoplasms, Lung Neoplasms

NCT03387865 2026-05-22

Bio-lung

Recruiting

500 enrolled

Thoracic

Lung Neoplasms, Neoplasms

NCT05119244 2026-05-06

ECP

Phase NA Recruiting

150 enrolled

Thoracic

Marijuana Abuse, Lung Neoplasms

NCT04222335 2026-04-29

LUNG-RESIST

Phase NA Active not recruiting

80 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05306912 2026-04-29

KOBE

Phase NA Recruiting

60 enrolled

Thoracic

Lung Neoplasms

NCT06620835 2026-04-29

OPTALK

Phase 2 Recruiting

45 enrolled

Thoracic

Lung Neoplasms

NCT00898313 2026-04-27

Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer

Recruiting

4,000 enrolled

Thoracic

Lung Neoplasms

NCT02630615 2026-04-24

Circulating Tumor Cells (CTC) in Lung Cancer

Active not recruiting

80 enrolled

Thoracic

Lung Neoplasms, Neoplastic Cells, Circulating

NCT03987555 2026-03-18

Paclitaxel Therapeutic Drug Monitoring in Cancer Patients

Suspended

22 enrolled

BreastGynecologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Vulvar Neoplasms

NCT07163507 2026-03-18

RICEPS-2

Phase NA Not yet recruiting

50 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Clinical Trials

A Feasibility Study to Further the Development of Lung Cancer-based Precision Medicine

Bio-lung

ECP

LUNG-RESIST

KOBE

OPTALK

Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer

Circulating Tumor Cells (CTC) in Lung Cancer

Paclitaxel Therapeutic Drug Monitoring in Cancer Patients

RICEPS-2